What's the end game on white collar and medical rollups?

Recently looked at DD to help my fund look at potentially launching a platform in one of the popular white collar services roll-ups (think accounting, wealth management, consultancy). These are great businesses. There are theoretical multiple arbitrage and operating leverage opportunities. But I can't get over the fact that there is no real exit strategy that makes sense.

Most of these businesses generate revenue through the senior practitioners' relationships. Instead of the $0.5-5M a year they bank from LLC distributions, you are trying to sell them on a equity story with multiple expansion. Get a slice of our big pie vs. eat your whole small pie. BUT I don't think these operators really have a path to a full liquidity until they retire.

Even if all the growth and multiple expansion are realized, the next buyer needs these people incentivized and working, not off to a beach after $10-20M+ liquidity event. So you can't really cash these people out in a meaningful way other than a small slice that they would have made anyways by just being a partner in the original small practice.

So, I went around to my contacts in healthcare PE space and asked how they model these exits for medical roll-ups. I really could not get a straight answer out of all the smart people I talked to. These docs who were practice owners have turned into salaried employees with phantom equity. A lot of the times there is friction and motivation issues. Nobody seems to know where the big platforms owned by UMM/MF are going to exit, once the hot potato recap games come all the way downstream. 

What am I missing? Has there ever been a great exit in a professional services or medical practice roll-up where the original sellers found a way to get paid out and transition the business to the next buyer?

4 Comments
 

Based on the most helpful WSO content, here are some insights on the end game for white collar and medical rollups:

Key Challenges:

  1. Revenue Dependency on Senior Practitioners:

    • These businesses often generate revenue through the relationships and expertise of senior practitioners.
    • Convincing these practitioners to buy into an equity story with multiple expansion can be challenging, as they might prefer their current earnings from LLC distributions.
  2. Exit Strategy Concerns:

    • Practitioners may not have a clear path to full liquidity until retirement.
    • Even with growth and multiple expansion, the next buyer needs these key individuals to remain incentivized and working, not retiring after a significant liquidity event.
  3. Motivation and Friction Issues:

    • In healthcare rollups, former practice owners turned salaried employees with phantom equity can face motivation issues.
    • Friction can arise when these individuals feel they are not adequately compensated or valued in the new structure.

Insights from Healthcare Rollups:

  • Platform and Bolt-On Strategy:

    • Successful rollups often start with acquiring a larger "mothership" asset, which serves as a platform for further bolt-on acquisitions.
    • This approach can create a more stable and scalable business model.
  • Operator Involvement:

    • Having operators who understand the businesses inside out is crucial. This helps in identifying synergies and managing central costs effectively.
    • Knowing which systems to replace and who needs to leave is essential for smooth integration.
  • Financing and Leverage:

    • Financing the bigger group is easier, and bolt-ons can often be financed 100% if the original platform is conservatively financed.
    • Leveraging up to 3x with current debt agreements can allow for acquisitions without equity, but this requires careful management.

Potential Solutions:

  1. Incentive Structures:

    • Develop incentive structures that align the interests of senior practitioners with the long-term goals of the rollup.
    • Consider offering equity stakes or profit-sharing arrangements that provide meaningful compensation and motivation.
  2. Succession Planning:

    • Implement robust succession planning to ensure a smooth transition when senior practitioners retire.
    • Identify and groom potential successors within the organization to maintain continuity.
  3. Clear Exit Strategy:

    • Define a clear exit strategy that outlines how practitioners can achieve liquidity while ensuring the business remains attractive to future buyers.
    • Explore options such as partial buyouts, earn-outs, or phased exits to balance liquidity needs with business continuity.

Conclusion:

The end game for white collar and medical rollups involves addressing the challenges of revenue dependency on senior practitioners, motivation issues, and defining a clear exit strategy. Successful rollups often rely on a platform and bolt-on strategy, operator involvement, and careful financing. Developing incentive structures, succession planning, and a clear exit strategy can help overcome these challenges and create a sustainable and attractive business model for future buyers.

Sources: Healthcare Rollup Strategy, Doctor thinking of exit opportunities, No PE in my PA, Exit Ops - The End of The Show II, https://www.wallstreetoasis.com/forum/corporate/the-forgotten-cousin-of-finance-commercial-insurance?customgpt=1

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

As someone at a MFO as our private markets person the roll-up play in WM is going to end horribly, IMO. Like everything PE touches it made sense at first to have some aggregation for a myriad of reasons (tech, better breadth of investment capabilities, ability to hire specialists in niche areas like estate planning, etc.). But it's gone so far that there's what feels like hundreds of these trash WM roll-ups that have no path to exit at all other than selling to a larger fund which I think is a bad practice in general. I came from a wire house and people at these RIAs are there because they hated the big banks bull shit, but when you start ramming 100 RIAs together it starts to smell just like a wire. Same can be said for medical roll-ups, it's just a cash out for the docs but many of them realize it's a disaster on the other side for the next gen. Issue in medical is insurance and whatnot make it a rigged game for aggregators to win over the single practice docs, which ultimately hurts everyone, namely patients.

 
Most Helpful

Id saepe sed laudantium cumque mollitia eaque ut. Quasi possimus dolorem labore reiciendis odio et. Quia corrupti tempore earum distinctio.

Sint quod laborum corrupti ea. Et quis in molestiae repellat dignissimos. Perferendis impedit et eveniet alias magni. Eos sint cum ipsa. Quasi laudantium neque est in est unde quos.

Non voluptatem hic blanditiis numquam repellendus est. Tempore sit dolore voluptatem quibusdam ut. Incidunt laudantium aut et commodi quisquam quia. Tempore fugit nobis nostrum aut tempora.

Minima accusamus explicabo voluptatem architecto. Deserunt fuga aspernatur vel libero et. Aut quibusdam qui velit suscipit inventore sed dicta.

Career Advancement Opportunities

July 2026 Private Equity

  • The Riverside Company 99.6%
  • Blackstone Group 99.3%
  • KKR (Kohlberg Kravis Roberts) 98.9%
  • Warburg Pincus 98.5%
  • Vista Equity Partners 98.1%

Overall Employee Satisfaction

July 2026 Private Equity

  • Blackstone Group 99.6%
  • KKR (Kohlberg Kravis Roberts) 99.2%
  • The Riverside Company 98.9%
  • Ardian 98.5%
  • Starwood Capital Group 98.1%

Professional Growth Opportunities

July 2026 Private Equity

  • Bain Capital 99.6%
  • The Riverside Company 99.3%
  • Blackstone Group 98.9%
  • Starwood Capital Group 98.5%
  • KKR (Kohlberg Kravis Roberts) 98.1%

Total Avg Compensation

July 2026 Private Equity

  • Principal (9) $653
  • Director/MD (24) $547
  • Vice President (99) $363
  • 3rd+ Year Associate (104) $281
  • 2nd Year Associate (235) $272
  • 1st Year Associate (411) $229
  • 3rd+ Year Analyst (33) $157
  • 2nd Year Analyst (97) $134
  • 1st Year Analyst (272) $124
  • Intern/Summer Associate (38) $81
  • Intern/Summer Analyst (356) $61
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”